BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34657217)

  • 21. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study.
    Özdal Zincir Ö; Özdal U; Ünlü Ö; Demirci M; Katiboğlu AB; Egil E; Altan Şallı G
    Odontology; 2022 Apr; 110(2):330-337. PubMed ID: 34657217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
    Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
    Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effect of Standardized Extract and Fractions of
    Jahantiq AS; Ayatollahi Mousavi SA; Mohamadi N; Sharififar F
    Curr Drug Discov Technol; 2022; 19(5):e120522204695. PubMed ID: 35549875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata.
    Harley BK; Quagraine AM; Neglo D; Aggrey MO; Orman E; Mireku-Gyimah NA; Amengor CD; Jato J; Saaka Y; Fleischer TC
    PLoS One; 2022; 17(11):e0278096. PubMed ID: 36441750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 and thymoquinone: Connecting the dots.
    Ahmad A; Rehman MU; Ahmad P; Alkharfy KM
    Phytother Res; 2020 Nov; 34(11):2786-2789. PubMed ID: 32588453
    [No Abstract]   [Full Text] [Related]  

  • 29. Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole.
    Lu M; Li T; Wan J; Li X; Yuan L; Sun S
    Int J Antimicrob Agents; 2017 Feb; 49(2):125-136. PubMed ID: 28040409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.
    Gholamnezhad Z; Havakhah S; Boskabady MH
    J Ethnopharmacol; 2016 Aug; 190():372-86. PubMed ID: 27364039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral candidiasis.
    Millsop JW; Fazel N
    Clin Dermatol; 2016; 34(4):487-94. PubMed ID: 27343964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
    de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
    BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
    Ning Y; Ling J; Wu CD
    Arch Oral Biol; 2015 Oct; 60(10):1565-70. PubMed ID: 26263544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-protective and anti-cancer therapeutic potential of Nigella sativa.
    Shafiq H; Ahmad A; Masud T; Kaleem M
    Iran J Basic Med Sci; 2014 Dec; 17(12):967-79. PubMed ID: 25859300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects.
    Forouzanfar F; Bazzaz BS; Hosseinzadeh H
    Iran J Basic Med Sci; 2014 Dec; 17(12):929-38. PubMed ID: 25859296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymoquinone and its therapeutic potentials.
    Darakhshan S; Bidmeshki Pour A; Hosseinzadeh Colagar A; Sisakhtnezhad S
    Pharmacol Res; 2015; 95-96():138-58. PubMed ID: 25829334
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.